Pizzie Nick 4

What Happened

• Nick Pizzie, Chief Financial Officer of Axsome Therapeutics (AXSM), was granted 8,188 performance stock units (PSUs) on April 21, 2026. The PSUs were awarded at $0.00 per unit (no cash paid) and are a contingent right to receive common stock if vesting conditions are met.

Key Details

• Transaction type: Award/Grant (derivative) — SEC Form 4 reported acquisition code "A"
• Transaction date: 2026-04-21; filing date: 2026-04-23 (timely within the usual 2-business-day Form 4 window)
• Amount granted: 8,188 PSUs at $0.00 per unit; reported dollar value at grant: $0
• Shares owned after transaction: Not disclosed in the filing
• Footnotes: F1 — Each PSU represents a contingent right to one share of common stock. F2 — PSUs vest only upon achievement of specified sales and commercial launch milestones and subject to continued service on each vesting date.

Context

• This was an equity compensation grant rather than an open-market purchase or sale. PSUs are contingent awards that convert to shares only if performance and service conditions are satisfied; they do not represent immediate ownership or a cash transaction. Such grants are commonly used for executive incentive pay and do not by themselves indicate an insider buying or selling for investment purposes.